Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Yuping Gong"'
Autor:
Kai Shen, Jie Huang, Chenlu Yang, Xiao Shuai, Yong Guo, Liping Xie, Jianjun Li, Yongqian Jia, Yuping Gong, Ting Niu, Hongbing Ma
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) have revolutionized the treatment of acute promyelocytic leukemia (APL). However, the management of high-risk APL has not been conclusively established. The optimal dosage of anthr
Externí odkaz:
https://doaj.org/article/6366df56d2904d19a4c6a55d31460fee
Autor:
Mingyuan Sun, Qingsong Yin, Yang Liang, Chunkang Chang, Jing Zheng, Jian Li, Chunyan Ji, Huiying Qiu, Junmin Li, Yuping Gong, Sheng Luo, Yan Zhang, Rumei Chen, Zhenwei Shen, Zenglian Yue, Siyuan Wang, Qingmei Shi, Jason Yang, Jie Jin, Jianxiang Wang
Publikováno v:
Blood Science, Vol 6, Iss 3, p e00196 (2024)
Ivosidenib, an isocitrate dehydrogenase 1 (IDH1) inhibitor, has demonstrated clinical benefits in a pivotal study (AG120-C-001) in patients with IDH1-mutated (mIDH1) acute myeloid leukemia (AML). A registry study (CS3010-101: NCT04176393) was conduct
Externí odkaz:
https://doaj.org/article/f2902b371ae34d948a11a6142a5bb49e
Autor:
Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Ruibin Huang, Shuye Wang, Zeping Zhou, Guolin Yuan, Meijuan Huang, Li-E Lin, Shifeng Lou, Yanping Song, Qingchi Liu, Hu Zhou, Heng Mei, Yu Hu
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 47, Iss , Pp 101096- (2024)
Summary: Background: Primary immune thrombocytopenia (ITP) is an autoimmune disease, and rituximab (RTX) induces long-term effect as second-line treatments. Zuberitamab is an innovative anti-CD20 monoclonal antibody, which was first developed in Chin
Externí odkaz:
https://doaj.org/article/ae82b070001b4f1389c25a1987cdf243
Autor:
Jinjun Yang, Lei Zhao, Yu Wu, Ting Niu, Yuping Gong, Xinchuan Chen, Xiaoou Huang, Jiazhuo Liu, Yang Dai, Hongbing Ma
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21111-21117 (2023)
Abstract Background The clinical significance of protein tyrosine phosphatase nonreceptor type 11 mutation (PTPN11mut) in acute myeloid leukemia (AML) is underestimated. Methods We collected the data of AML patients with mutated PTPN11 and wild‐typ
Externí odkaz:
https://doaj.org/article/7ab46c18738b46b6953282996115ea69
Publikováno v:
Dianxin kexue, Vol 39, Pp 1-16 (2023)
Unmanned aerial vehicle (UAV) communication network is an important part of the future integrated space-aerial-ground network, and an effective support to achieve the global three-dimensional coverage of the communication network.The open characteris
Externí odkaz:
https://doaj.org/article/a845d7b3294148cd9ce50eacb73788a6
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-19 (2023)
Abstract Peripheral T-cell lymphomas (PTCLs) are a group of highly aggressive malignancies with generally poor prognoses, and the first-line chemotherapy of PTCL has limited efficacy. Currently, several novel targeted agents, including histone deacet
Externí odkaz:
https://doaj.org/article/8a0e7ded7b2c47a1b6c886cc2649446d
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Objective The objective of the study was to determine the prognosis and risk factors for additional sex combs like 1 (ASXL1) mutations in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Population and Methods T
Externí odkaz:
https://doaj.org/article/4e76f04c141c42cf86813d8e9fb88eec
Publikováno v:
Heliyon, Vol 9, Iss 12, Pp e22813- (2023)
Purpose: To investigate influencing factors of cancer-related fatigue (CRF) in adult patients with acute leukemia (AL). Methods: A total of 288 adult patients diagnosed with acute leukemia in West China Hospital were included in this study. A cross-s
Externí odkaz:
https://doaj.org/article/6179d4c4eeb9450a8ab9a3979d55e04c
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6523-6535 (2023)
Abstract Aims The purpose of this prospective, randomized study was to investigate the effectiveness and safety of the ixazomib+cyclophosphamide+dexamethasone (ICd) and ixazomib+dexamethasone (Id) regimens in newly diagnosed multiple myeloma (NDMM) w
Externí odkaz:
https://doaj.org/article/d0b4e9aab4ca4f9297f52fe456f28073
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Increasing germline gene mutations have been discovered in haematological malignancies with the development of next-generation sequencing (NGS), which is critical for proper clinical management and long-term follow-up of affected
Externí odkaz:
https://doaj.org/article/7c2cb7297d9242c4a14e87bcb920b5cc